Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-26-182352
Filing Date
2026-04-27
Accepted
2026-04-27 17:01:17
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 d108102d424b3.htm 424B3 100978
2 GRAPHIC g108102g02a01.jpg GRAPHIC 46095
  Complete submission text file 0001193125-26-182352.txt   156745
Mailing Address 441 NINTH AVENUE, 14TH FLOOR NEW YORK NY 10001
Business Address 441 NINTH AVENUE, 14TH FLOOR NEW YORK NY 10001 212-776-4381
Ovid Therapeutics Inc. (Filer) CIK: 0001636651 (see all company filings)

EIN.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-295218 | Film No.: 26901883
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)